Cooley advised Bellicum Pharmaceuticals on its $69 million public offering of 5,750,000 shares of common stock, including the exercise by the underwriters of their option to…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now